BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 23, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Onrigin laromustine regulatory update

Vion submitted an NDA to FDA for Onrigin laromustine injection to treat patients aged 60 and...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >